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Early development of the rostral forebrain (RF) in vertebrates is accompanied by the inhibition of two homeobox regulators, Otx2 and Pax6 in
the rostral sector of the anterior neural plate, further giving rise to the RF. However, the precise molecular mechanism and meaning of this
inhibition is still obscure. We now demonstrate that the activity of the Anf homeodomain protein is necessary and sufficient for the anterior
inhibition of Otx2 and Pax6. Specifically, we show that knockdown of the Xenopus laevis Anf, Xanf, by antisense morpholino oligonucleotides
results in the anterior expansion of Otx2 and Pax6 expression into the presumptive RF territory. Furthermore, by overexpressing hormone-
inducible activator- and repressor-fused variants of Xanf in the absence of protein synthesis, we present evidence that Xanf can directly
downregulate Otx2 and Pax6 but not the more rostrally expressed Bf1, Bf2, Fgf8 and Nkx2.4. These results explain how the inhibitory activity of
Xanf can discriminate RF regulators in favor of posterior forebrain ones. Assuming that the Anf type of homeobox is specific for vertebrates, our
data suggest that the emergence of Anf in evolution could be a critical event for RF development in vertebrates through the elimination of
homologues of modern posterior forebrain regulators from the rostral sector of the anterior neural plate.
© 2007 Elsevier Inc. All rights reserved.Keywords: Homeobox genes; Forebrain; Patterning of the neural plateIntroduction
One of the characteristic features sharply distinguishing
vertebrates from their nearest relatives, lower chordates, is a
complex brain (Shimeld and Holland, 2000). In contrast to
vertebrates, lower chordates have only a slight thickening of the
rostral part of the neural tube, and in a surface view this
resembles posterior units of the vertebrate brain. Consistently,
comparative analysis with marker genes as well as precise
anatomical studies indicates that lower chordates have no
anatomical homologues of the rostral part of the vertebrate
forebrain (Holland and Holland, 1999; Williams and Holland,
1998). This part of the forebrain is located anterior to the zona
limitans intrathalamica (zli), a narrow transverse compartment
that delimits the rostral part of the vertebrate forebrain, and
includes the telencephalon, bilateral eyes, hypothalamus and
prethalamus, the posterior part is distinct, and is composed by
the thalamus pretectum and some other structures (Holland and⁎ Corresponding author.
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Recent studies have established that the core mechanism
ensuring development of the rostral forebrain is based on
inhibition of the caudalizing influence of Wnt signaling within
the anterior neuroectoderm (Niehrs, 1999). This inhibition is
achieved via activity of the Wnt antagonists secreted by cells of
the head mesoderm and the anterior neural and non-neural
ectoderm (cerberus, Dkk, sFRP), as well as via inhibition of
Wnt transcription by specific transcriptional repressors that
operate within cells of the anterior neuroectoderm (Six3, tcf3)
(Glinka et al., 1998; Lagutin et al., 2003; Piccolo et al., 1999;
Uren et al., 2000). In response to decreased Wnt signaling, the
rostral forebrain regulators (Bf1, Emx1) begin to be expressed
mostly in cells of the anterior part of the neural plate
corresponding to the future rostral forebrain. At the same
time, the expression of posterior forebrain regulators (Otx2 and
Pax6) is inhibited in this territory.
In contrast, artificial prevention of the inhibition of Wnt
signaling in frog embryos leads to anterior expansion of more
caudal brain structures and a reduction of the rostral forebrain
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masterblind mutants that have increased Wnt signaling, the
telencephalon and eyes appear to be substituted by more
posterior diencephalic structures, which are expanded up to the
rostral end of the neural tube (Heisenberg et al., 1996; Masai et
al., 1997). A similar effect was observed in mice bearing
mutations in the homeodomain protein Six3, a direct transcrip-
tional inhibitor of Wnt signaling (Lagutin et al., 2003).
It is still unknown, however, whether cessation of Wnt
signaling is the only factor preventing expansion of more
posterior fates towards the anterior. Specifically, it is unclear
whether there are inhibitors that directly suppress the expression
of genes responsible for specification of more posterior brain
regions in cells of the presumptive forebrain. Alternatively, the
latter genes could be silent in cells of the presumptive rostral
forebrain simply due to the lack of Wnt signaling, which is
necessary for their activation (Wilson and Houart, 2004).
After taking into consideration the literature and our own
data, we hypothesized that one such repressor that ensures
inhibition of the posterior forebrain fate within the prospective
rostral forebrain territory, could be the product of the homeobox
gene Anf. Anf is the earliest transcriptional repressor function-
ing specifically in the anterior neuroectoderm (Ermakova et al.,
1999; Kazanskaya et al., 1997; Zaraisky et al., 1992). A key role
of Anf for rostral forebrain development is confirmed by the fact
that mutations in the mammalian Anf, HESX1/Hesx1, can elicit
a reduction of rostral forebrain size in both humans and mice
(Dattani et al., 1998; Martinez-Barbera et al., 2000). In contrast,
overexpression of the Xenopus Anf, Xanf1 can elicit an
enlargement of the rostral forebrain and inhibit genes that
normally express in more posterior brain regions (Ermakova et
al., 1999). Despite these studies, it still unknown if the activity
of endogenous Anf during normal development is essential to
repress transcriptional regulators that specify more posterior
fates in the presumptive rostral forebrain territory.
In an attempt to answer this question, we demonstrate in the
present work that downregulation of the Xenopus Anf, Xanf, by
antisense morpholino oligonucleotides (MO) can elicit an
anterior shift in the expression of at least two posterior forebrain
regulators Otx2 and Pax6, and inhibition of expression of the
rostral forebrain regulators Bf1, Bf2, Fgf8 and Nkx2.4. We also
observe the differentiation of retinal pigment epithelium, which
normally is characteristic for the posterior forebrain, within the
rostral forebrain of embryos treated by anti-Xanf MO. More-
over, overexpression of Otx2 in regions where endogenous
Xanf is expressed, elicits effects similar to those induced by the
Xanf MO. All together, these results indicate a role for Xanf as
an essential suppressor of posterior forebrain fate within the
presumptive rostral forebrain region.
Materials and methods
Plasmid constructions and mRNA synthesis
The plasmid containing Otx2 cDNAwas generated by subcloning the Otx2
cDNA coding frame, obtained by PCR, into the AgeI and XhoI sites of pSP-
GFP-Xanf1-BDGR (Ermakova et al., 1999) in place of GFP-Xanf1. The
plasmids containing Xanf1, Xanf1-BDGR, EnR-Xanf1-BDGR cDNA andVP16-Xanf1-BDGR cDNAwere previously described (Ermakova et al., 1999).
To generate a vector suitable for synthesis of Xanf2 mRNA, the full-length
coding fragment of Xanf2 cDNAwas obtained by PCR from a previously cloned
Xanf2 cDNA insert in the pB42 plasmid (Martynova et al., 2004) with the
following pair of primers: forward: 5′-ATAACCGGTGACAACGTTCCCATT;
reverse: 5′-TATGTCGACTAATGGAGATCCTCATTCTTC. The obtained PCR
fragment was subcloned by AgeI and SalI into the p35T plasmid. To generate a
vector for synthesis of deltaXanf1 mRNA deprived of the anti-Xanf MO target
site (see below), a fragment of Xanf1 cDNA was obtained by PCR from the
p35T-Xanf1 plasmid (Ermakova et al., 1999) with primers: forward: 5′-
CACCATGGACAACACCGAGGACAAAGGATCCAGTCTGATG; reverse:
5′-TAGAAAGCTTCATTCCTGTATCTTTGATG. The obtained PCR fragment
was subcloned by NcoI and HindIII into the p35T plasmid. All mRNA used for
microinjections was synthesized by SP6 mMESSAGEMACHINE kit (Ambion)
from the aforementioned plasmids linearized by VspI. POtx2-RFP plasmid was
generated by subcloning of 2.3 kb PstI-BamHI fragment of the 5′ flanking
region of the Xenopus laevis Otx2 gene (gift from E. Boncinelli) into PstI-
BamHI sites of the pDsRed2 promoter-less plasmid (Clontech).
Morpholino and mRNA microinjections
Xenopus eggs were fertilized in vitro and de-jellied in 2% cysteine at pH 7.8.
Synthetic mRNAs were mixed with fluorescein lysine dextran (FLD) and
microinjected (100–300 pg/blastomere) into embryos at the 2- to 32-cell stage in
different experiments. When it was necessary, the embryos were placed in
cycloheximide (10 μg/ml) and/or dexamethasone (2 μmol) solutions. The MO
(anti-Xanf1 MO 5′-ATCCTTTCTGAAGAGCAGGAGACAT; anti-Xanf2 MO
5′-ATCCTTTCTGGAGACCAGTAGACAT and control ani-Xanf-misMO 5′-
ATCATTGCTGAAGACCAGGATACAT) was mixed with FLD and micro-
injected at a concentration of 0.2 mM into animal poles at the two blastomere
stage (3–6 ng of MO/blastomere). To test the effectiveness of MO inhibition,
synthetic mRNAs encoding Xanf1 and Xanf2 pseudo alleles were mixed and
microinjected (1 ng/oocyte each) alone or in a mixture with MO into X. laevis
oocytes (10 ng of MO/oocyte). Incubation of the experimental and control
(injected with EGFP mRNA, 1 ng/oocyte) oocytes followed by immunoblotting
were performed according to the standard protocol. Polyclonal antibodies
against Xanf1 recombinant protein were previously generated in rabbit (our
unpublished data).
Whole-mount in situ hybridization, cell proliferation and apoptosis
detection
Embryonic stages were determined according to Normal Table of X. laevis
(Nieuwkoop and Faber, 1967). The whole-mount in situ hybridization was
performed as described (Ermakova et al., 1999). After the procedure, some
embryos were bleached by 10% H2O2 in 50% ethanol. To visualize mitotic cells,
a part of the embryos fixed for in situ hybridization were immunostained with
anti-phosphohistone H3 antibody (Upstate Biotechnology), and the antibody
was detected as described (Saka and Smith, 2001). Apoptotic cells were detected
by a variant of the TUNEL method (Hensey and Gautier, 1998). The embryos
were embedded in paraffin, and the number of the mitotic or apoptotic cell nuclei
was counted on 12-μm medial sagittal sections within the anterior neural plate
territory (grey thickened part of the neural plate in Supplementary Fig. 1B). The
total number of labeled nuclei on the aforementioned territory was counted on 5
successive medial sagittal sections for 10 embryos for each condition
(microinjected with either anti-Xanf or anti-Xanf-mis MO and un-injected
control).
Transgenic embryos
To construct the double-cassette vector, the Otx2 cDNA full-length coding
region was obtained by PCR with the following primers: forward 5′-
ATTACCGGTCGCCACCATGATGTCTTATCTCAAGCAACC; reverse 5′-
ATAGCGGCCGCAGGAAAGTTCTTCACAAAACCTGGAA.
The obtained PCR fragment was subcloned by AgeI and NotI into the pRx-
GFP-pCAR-RFP double-cassette vector (a gift of R. Grainger) instead of GFP
cDNA. Thereafter, a 2.2-kb fragment of the Xanf1 promoter from pXanf1-EGFP
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pCAR-RFP instead of the Rx promoter. The resulting double-cassette vector was
named as pXanf-Otx2-pCardActin-RFP. The control, single-cassette vector,
pCardActin-RFP, was generated by excision of the Rx-Otx2 cassette with XhoI
and NotI from pRx-Otx2-pCAR-RFP followed by blunted re-ligation. For
transgenic experiments, both vectors were linearized by SfiI and purified by
Qiagen columns. Transgenic embryos were generated by the REMI technique as
described previously (Offield et al., 2000). About 3000 eggs in total (1500 with
the Otx2 expressing construct and 1500 with the control one) were used for
sperm nuclei transfer in three independent experiments which finally gave 15%
of normal embryos. One half of those embryos was collected at the midneurula
stage (stage 14) and subjected to whole-mount in situ hybridization with a
mixture of probes to Bf1 and cardiac actin mRNA. Another half of the embryos
were grown up to the tadpole stage (5 days) and analyzed for correlation of brain
abnormalities with RFP fluorescence in muscle cells. As a result, 55 control and
57 ectopic Otx2 expressing transgenic embryos were analyzed in total (25% of
all embryos successfully developed in three experiments).Results
Downregulation of Xanf elicits an anterior shift of expression
in posterior forebrain markers
To study the role of Xanf during forebrain development, we
generated antisense morpholino oligonucleotides (MO) against
both X. laevis Xanf pseudo alleles, Xanf1 and Xanf2
(Kazanskaya et al., 1997), and then tested whether these MO
can specifically inhibit translation of Xanf mRNA using the
Xenopus oocyte expression system and in wild type embryos.
During this, the presence of Xanf protein was detected by
immunoblotting with polyclonal antibodies, which could
recognize both Xanf pseudo alleles. As a result, we established
that an equimolar mixture of both MO (anti-Xanf MO hereafter)
could effectively and specifically inhibit translation of both the
microinjected synthetic and the endogenous Xanf1 and Xanf2
mRNA in oocytes and embryos (Supplementary Fig. 1A upper
and bottom panel respectively). In contrast, no inhibition was
detected when the control anti-Xanf-mis MO, which contains
four and five mismatches with anti-Xanf1 and anti-Xanf2 MO
respectively, was microinjected in oocytes alongside the anti-
Xanf MO (Supplementary Fig. 1A upper panel, line 5 from the
left).
To investigate the effects of MO-elicited suppression of Xanf
mRNA translation on early neural plate patterning, we analyzed
changes in expression of the following marker genes normally
expressed in the neural plate at different anterior–posterior
levels: HoxB9—trunk region of the neural plate (Sharpe, 1991);
Engrailed2—the most rostral part of the future hindbrain
(Hemmati-Brivanlou et al., 1991);Wnt8—bilateral longitudinal
rows of cells in the trunk region of the neural plate and two
bilateral transverse stripes in the presumptive mesencephalon;
Otx2—presumptive mes- and diencephalon, presumptive mid-
line of the dorsal telencephalon (Pannese et al., 1995); Pax6—
several expression domains within the neural plate, including
two longitudinal bands in the trunk region, two small patches of
expression in the presumptive hindbrain and a broad area
covering the presumptive diencephalon and dorsal telencepha-
lon (Hirsch and Harris, 1997); Nkx2.4—presumptive ventral
diencephalon adjacent to the anterior tip of the floor plate(Small et al., 2000); Bf2—presumptive ventral diencephalon
(Mariani and Harland, 1998); Bf1—prospective telencephalon,
part of the rostral diencephalon (Bourguignon et al., 1998);
Fgf8—three narrow bands corresponding to the prospective
mid-hindbrain boundary, telencephalon and ventral limits of the
prospective cement gland; Six3—broad region including
prospective di- and telencephalon (Zhou et al., 2000); XAG—
presumptive cement gland (Sive et al., 1989). In addition, we
investigated the effect of suppression of XanfmRNA translation
on the expression of Xanf itself, whose expression at the mid-
neurula stage is present in prospective ventral and dorso-rostral
part of the diencephalon and the entire telencephalon (Kazans-
kaya et al., 1997; Zaraisky et al., 1995).
To precisely map the expression domains of each of these
genes with respect to the expression zone of Xanf, we performed
in situ hybridization of embryos split bilaterally before the
hybridization procedure. During the latter procedure, one half of
each embryo was hybridized with the Xanf1 probe (which also
effectively recognized Xanf2 mRNA), and the other half with a
probe to one of themarker genes. After careful comparison of the
hybridized halves of each embryo (see representative examples
on Supplementary Figs. 1C–H), the following features of the
expression domains of the selected marker genes with respect to
the expression domain of Xanf were established.
The expression domains of HoxB9 (Fig. 1A), Engrailed2
(Fig. 1G) and the trunk region of the Pax6 (Fig. 1D) and Wnt8
(Fig. 1B) expression patterns do not overlap with the Xanf
expression area, and are located posterior to Xanf expression
(schematic representations on Figs. 1A2, B2 and G2). The
schematic representation for bilateral broken transverse stripes
forWnt8 expression (Fig. 1B and on Figs. 1A2, B2 and G2) are
within the territory of the presumptive diencephalon, which at
the mid-neurula stage is located slightly anterior to the two
transverse expression domains of Engrailed2. The latter
domains, in turn, demarcate the position of the presumptive
mid-hindbrain boundary. Otx2 is expressed in a ring-shaped
domain (Fig. 1C) surrounding the area of Xanf expression
(schematic representations on Fig. 1C2). The posterior and
lateral parts of the Otx2 expression domain are localized within
the anterior neural plate, while its rostral portion corresponding
to the presumptive cement gland area abuts the anterior margin
of the plate rostrally (see also Supplementary Figs. 4H and I).
Interestingly, at earlier stages Otx2 is expressed in a continuous
domain, but by the mid-neurula stage, its expression appears to
be inhibited in the central part of this domain. The inhibited
region corresponds to the Xanf expression domain (Ermakova
et al., 1999; Kazanskaya et al., 1997; Martynova et al., 2004).
The anterior horseshoe-shaped domain of Pax6 (Fig. 1D)
crosses the anterior segment of the neural plate and overlaps
with the Xanf expression domain at its medial sector (schematic
representations on Fig. 1D2). Similar to Otx2, at earlier stages,
Pax6 expression is stronger within the area of overlap with the
Xanf expression domain, but its expression decreases medially
by the mid-neurula stage (Ermakova et al., 1999). At the same
time, the area where Pax6 expression is reduced has a smaller
size than the similar hole-like area within the Otx2 expression
domain (compare Figs. 1C and D). In contrast to Otx2, Pax6
Fig. 1. Effects of anti-Xanf MO on expression of different marker genes in the neural plate of Xenopus laevis midneurula embryos (stage 14). (A–J) Expression of
Hox9, Wnt8, Otx2, Pax6, Six3 and Engrailed2 (in situ hybridization with the mixture of probes), Xanf, Bf2 and Engrailed2 (in situ hybridization with the mixture of
probes), Bf1, Fgf8 and Xanf respectively in control embryos. (A1–J1) Expression of the aforementioned markers in embryos microinjected with anti-Xanf MO. Note
the anterior expansion of expression of the posterior forebrain markers (Otx2 and Pax6) in contrast to inhibition of the rostral ones (Bf1, Bf2, Fgf8). (A1′–J1′)
Distribution of FLD tracer in embryos shown in panels A1–J1 is shown in fluorescence. (A2–J2 and A3–J3) Schematic diagrams of expression domains (purple) of
the aforementioned marker genes in control (A2–J2) and experimental (A3–J3) embryos are shown in comparison with the normal expression domain of Xanf (pink).
All embryos are shown from the anterior, dorsal side up. Approximate position of the anterior margin of the neural plate is indicated by the red dotted line.
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sponding to the most intense expression of Xanf, namely in a
more medial, than in case of Otx2, sector of the Xanf expression
domain (Fig. 1D2). Moreover, within the latter sector, the
inhibition of Pax6 is deeper in the most anterior and posterior
parts of the Xanf expression domain (bracketed on Supplemen-
tary Fig. 1D), which correspond to maximal Xanf expression
levels. In contrast to Otx2 and Pax6, the expression domains of
Bf2 (Fig. 1G), Bf1 (Fig. 1H) and Nkx2.4 (not shown), as well as
the medial stripe of Fgf8 expression (Fig. 1I), are located
entirely within the Xanf expression area (schematic representa-
tions on Figs. 1G2, H2, and I2 respectively). In contrast, the
Six3 expression domain (Fig. 1E) completely covers the latter
area (schematic representations on Fig. 1E2). Finally, the
expression domain of XAG abuts the Xanf expression domain at
its anterior (Figs. 1J and J2).
To study the effects of Xanf downregulation on the
expression of aforementioned marker genes, anti-Xanf MO
was microinjected into the animal dorsal blastomeres of
embryos at the 8- to 16-cell stage. The embryos were collected
for whole-mount in situ hybridization at the mid-neurula (stages
14–15) or mid-tailbud (stages 26–27) stages. At the mid-
neurula stage, no changes were observed in the expression
patterns of HoxB9 (Figs. 1A1 and A3), Engrailed2 (Figs. 1E1,
G1 and E3, G3), the trunk bands of the Pax6 expression (Figs.
1D1 and D3), Six3 (Figs. 1E1 and E3), Xanf itself (Figs. 1F1
and F3) and XAG, except for a slight posterior expansion of
expression of XAG (Figs. 1J1 and J3). It is also interesting to
note that we did not detect any changes in the expression pattern
for one of the Wnt genes, Wnt8, which is implicated in
regulation of the anterior neural plate (Figs. 1B1 and B3).
In contrast, dramatic perturbations were observed in
expression patterns of more anterior genes. Thus, expression
of Otx2 and Pax6 expands medially and rostrally thereby
occupying the territory in which Xanf is normally expressed
(Figs. 1C1 and C3; D1 and D3). The effect was seen in all
embryos with MO in the anterior neuroectoderm, but was
expressed at various extents within different embryos depend-
ing on the distribution of MO. However, in the most dramatic
instances, when the microinjected MO appeared to be perfectly
located within the anterior neuroectoderm (15 embryos out of
45 in 2 experiments), expression of Otx2 and Pax6 completely
covered the medial sector of the neural plate.
To control specificity of the effects elicited by anti-Xanf MO,
we tested the ability of delta-Xanf1 mRNA, which encoded a
version of Xanf1 mRNA deprived of the anti-Xanf MO target
site (see Matherials and methods), to rescue the MO-induced
expansion of Otx2 expression. As a result of subsequent
microinjection of anti-Xanf MO and delta-Xanf1 mRNA into
embryos, we observed inhibition, instead of expansion, of Otx2
expression (Supplementary Figs. 2A–A″, 19 embryos) and
Pax6 expression (Supplementary Figs. 2D–D″, 17 embryos).
These results confirm the specificity of the Xanf MO effects.
In contrast to the expansion of Otx2 and Pax6 expression,
several other markers, Bf1, Bf2, Fgf8 and Nkx2.4 (17 out of 32,
15 out of 40, 16 out of 30 and 14 out of 35 embryos respectively,
in 2 experiments) which are normally expressed within the Xanfexpression area, were significantly downregulated (Figs. 1H1
and H3 for Bf1, G1 and G3 for Bf2, I and I3 for Fgf8 and not
shown for Nkx2.4). Depending on the distribution of the MO,
the expression of the effect varied between embryos, similar to
that observed for Otx2 and Pax6.
As we established by analyzing histological sections, more
then one third of the number of embryos microinjected with
Xanf MO that demonstrated expression abnormalities had FLD
labeled cells exclusively in the anterior neural plate, but not in
the underlying endomesoderm (see a representative example on
Supplementary Figs. 1I and I′). These data confirm that the
observed abnormalities did not result for an indirect influence of
the MO via underling inducing tissue, but was caused by the
autonomous action of the MO within the neuroectodermal cells.
Importantly, the observed effects cannot be attributed to
possible changes in cell proliferation or apoptosis rates, which
might be caused by the anti-Xanf-MO. As we determined, both
of these rates did not change significantly in the anterior neural
plates of embryos microinjected with either anti-Xanf or anti-
Xanf-mis-MO (Supplementary Figs. 1J and K).
Similar expression abnormalities were observed in the Xanf
morphants collected at the mid-tailbud stage. Thus, there was a
general anterior shift ofOtx2 expression in the brains of theMO-
injected embryos relative to those of the non-injected embryos
(10 out of 25 embryos in 2 experiments) (Figs. 2A and A1). A
less pronounced shift towards the telencephalon was observed
for Pax6 expression (15 out of 27 embryos in 2 experiments)
(Figs. 2B and B1). On the other hand, the expression of the
rostral forebrain markers, Bf1 and Nkx2.4, were significantly
suppressed (13 out of 25 and 12 of 24 embryos respectively, in 2
experiments) (Figs. 2C and C1; D and D1). At the same time, in
contrast to the mid-neurula stage, complete suppression of Bf1
expression at the mid-tailbud stage was never observed. It is
possible that this indicates that while Xanf activity is essential
for the initial phase of Bf1 expression, the later phases of
expression are controlled independent of Xanf.
The expression of endogenous Xanf in tailbud stage
morphants was also examined. In controls at this stage, the
expression of Xanf is localized at the front of the rostral tip of
the neural tube, in the anterior pituitary anlage. As shown
previously, Xanf1 could negatively regulate its own transcrip-
tion (Ermakova et al., 1999). Therefore, one may expect to
detect some expansion of the Xanf expression area in
morphants. Indeed, we observed a significant enlargement of
the Xanf expression area (12 out of 26 embryos in 2
experiments) (Figs. 2E and E1). However, in all cases, this
occurred in the area anterior to the neural tube.
As Xanf was expressed at the tailbud stage outside the brain
anlage, we had an opportunity to use this peculiarity of Xanf
expression to further confirm the specific influence of anti-Xanf
MO. For this purpose, we performed whole-mount in situ
hybridization on morphants using a mixture of two probes to
detect expression of Xanf and Nkx2.4. The latter gene was
chosen for two reasons; first, it was negatively regulated in the
morphants and second, its normal expression domain at the
tailbud stage was spatially separated from that of Xanf. As a
result of this experiment, we demonstrated that in morphants,
Fig. 2. Abnormal expression of the posterior and anterior forebrain markers is
preserved in late tailbud-stage embryos (stages 26–28) microinjected with anti-
Xanf MO. (A–E) Expression of Otx2, Pax6, Bf1, Nkx2.4 and Xanf in control
embryos. (F) Expression of Nkx2.4 and Xanf in the same control embryo as
revealed by double in situ hybridization with mixed probes to Nkx2.4 and Xanf
mRNA. (A1 and B1) Expression of Otx2 (A1) and Pax6 (B1) in embryos
microinjected with anti-Xanf MO demonstrates an anterior expansion that is
especially pronounced in the case of Otx2. (C1 and D1) Expression of Bf1 (C1)
and Nkx2.4 (D1) is inhibited in embryos microinjected with anti-Xanf MO. (E1)
In contrast to Bf1 and Nkx2.4, Xanf appears to be overexpressed when its
translation is inhibited by anti-Xanf MO. (F1) Anti-Xanf MO exerts an opposite
effect on the expression of Nkx2.4 and Xanf. (A1′–F1′) Distribution of FLD
tracer in embryos shown in panels A1–F1. All embryos are shown from the
anterior, dorsal side up. Red dotted line indicates rostral margin of the neural
tube as seen from the anterior. Abbreviations: cg—cement gland; p—pituitary;
tel—telencephalon.
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This illustrated specificity of the effects of anti-XanfMO (14 out
of 23 embryos in 2 experiments) (Figs. 2F and F1).
Xanf can directly inhibit expression of posterior but not
anterior forebrain markers
The results described above, as well as our previous data
(Ermakova et al., 1999), indicate that Xanf activity is essentialfor inhibiting the expression of mesencephalic and caudal
diencephalic genes (Otx2 and Pax6), and the activation of
rostral, diencephalic and telencephalic genes (Bf1, Bf2, Fgf8
and Nkx2.4).
To verify whether Xanf can directly regulate these genes in
living embryos, we designed experiments using dexametha-
sone-inducible activator- and repressor-fused variants of Xanf1.
This approach has a significant advantage over in vitro binding
assays such as EMSA, because it allows one to test the mode of
influence of a given transcription factor on the gene of interest
directly in living cells located in a desired region of the embryo.
We microinjected embryos with mRNA encoding the fusion
product of Xanf1 with the binding domain of glucocorticoid
receptor (BDGR) and either the repressor domain of the Dro-
sophila engrailed protein (EnR-Xanf1-BDGR) or the activation
domain of the herpes virus VP16 protein (VP16-Xanf1-BDGR).
Due to sequestration of BDGR by the hsp90 heat-shock
complex, the fusion proteins appear to be inactivated within
embryonic cells (Ermakova et al., 1999; Gammill and Sive,
1997). At the late mid-gastrula stage (stage 12), the micro-
injected embryos were placed into a 10 μg/ml cycloheximide
(CHX) solution for 1 h. According to the literature (Gammill
and Sive, 1997) and our own data (Martynova et al., 2004), this
treatment is sufficient to block more than 90% of normal total
protein synthesis. Next, dexamethasone (DEX) was added at a
final concentration of 2 μM, which resulted in the release of
previously accumulated EnR-Xanf1-BDGR or VP16-Xanf1-
BDGR from the hsp90 complex. Under these conditions, the
expression of only direct targets of Xanf could be affected due
to suppression of mRNA translation by CHX. The embryos
were collected after 2 h of incubation with CHX and DEX,
when untreated siblings reached the early mid-neurula stage,
and expression of the previously described genes was analyzed
by whole-mount in situ hybridization.
It should be noted that, at the same time, blocking overall
protein synthesis by CHX caused significant changes in normal
gene expression. As a result of mRNA stabilization (Duval et
al., 1990), the expression domains of genes that normally
initiated expression prior to CHX application (Bf1, Otx2,
Pax6) appeared more expanded (compare expression patterns
of these genes in the control and CHX-treated midneurula
embryos shown in Supplementary Figs. 3A–D and E–H). This
effect was especially pronounced in the case of Otx2. In
particular, an abnormal stripe of Otx2-expressing cells was
regularly seen along the neural plate midline (Supplementary
Fig. 3E). In contrast to controls, no anterior “holes” in the
expression domains of Otx2 and Pax6 appeared at the neurula
stage after CHX treatment (compare Supplementary Figs. 3A
and E, B and F). Due to this effect of RNA stabilization in CHX-
treated embryos, we were unable to conclude anything about an
inhibitory influence, which might be exerted on expression of
Otx2 by the repressor-fused construct, EnR-Xanf1-BDGR.
Indeed, Otx2 begins to be expressed in the dorsal ectoderm at
the early gastrula stage. Therefore, after CHX treatment its
transcripts had enough time to accumulate and stabilize in a
broad area by the late gastrula stage, i.e., by the time when EnR-
Xanf1-BDGRwas activated by DEX. As a result, we principally
489G.V. Ermakova et al. / Developmental Biology 307 (2007) 483–497could not distinguish a possible inhibitory influence of EnR-
Xanf1-BDGR on Otx2 expression due to the high background
caused by previously accumulated transcripts.
To avoid this obstacle, we shifted the CHX application time
to the early gastrula stage (stage 10.5). As a result, gastrulation
was blocked at the mid-gastrula stage (stage 11), and Otx2
expression in the dorsal ectoderm proceeded at low levels, whileFig. 3. Xanf can directly regulate the expression of Otx2 and Pax6 but not of Bf, B
EnR-Xanf1-BDGR (A–F) or VP16-Xanf1-BDGR (G–Q) in the animal corner o
microinjected with EnR-Xanf1-BDGR mRNAwere immersed in CHX solution at ea
midgastrula (stage 11) (A) or early neurula (stage 13) (B–F) and fixed for in situ hy
(stage 14) (B–F). (A and A′) Inhibition of Otx2 expression in the microinjected side
bottom. Midline of the presumptive neural plate is indicated by dotted line. (B–B′) In
embryo shown from the anterior, dorsal side up. Here and below, dotted line indicate
expression, which would correspond to the location of the microinjected cells, is se
(F and F′). (G–Q) Embryos microinjected with VP16-Xanf1-BDGR mRNA. Embr
DEX at early neurula (stage 13) and were fixed for in situ hybridization at midneuru
the microinjected side of the embryo shown from ventral side, anterior to the top. (G
shown from the dorsal side, anterior to the bottom. Note the different positions of a
each embryo. (H–H′) Expression of Pax6 demonstrates asymmetrical lateral expans
from the anterior, dorsal side up. (J–M) In contrast to Otx2 and Pax6, no asymm
microinjected cells, is seen in case of Bf1 (J and J′), Bf2 (K and K′), Fgf8 (L and
DEX without preliminary CX treatment elicits inhibition of Bf1 expression in the m
CX and DEX non-treated microinjected embryos. (P and P′) In contrast to Bf1, expr
be expanded towards the territory where Otx2 appeared to be inhibited in normal d
domain in CX and DEX non-treated microinjected embryos demonstrates a normaexpression of other tested genes did not begin at all. With this
reduced level ofOtx2 expression, we observed a clear inhibitory
effect of EnR-Xanf1-BDGR on the microinjected side of
embryos treated with DEX 1 h after CHX application (15 out of
20 embryos in two experiments) (Figs. 3A and A′).
In contrast to Otx2, the inhibitory effect of EnR-Xanf1-
BDGR on later expressing Pax6 could be easily observed inf2, Fgf8 and Nkx2.4. Embryos were microinjected with mRNA encoding either
f one of two animal dorsal blastomeres at the 8-cell stage. (A–F) Embryos
rly gastrula (stage 10.5) (A) or late gastrula (stage 12) (B–F), treated by DEX at
bridization at the late gastrula (stage 12) (A) or the midneurula stage equivalent
(arrow) of the midgastrula embryo shown from the dorsal side, anterior to the
hibition of Pax6 expression in the microinjected side (arrow) of the midneurula
s limits of the neural plate. (C–F) In contrast to Otx2 and Pax6, no inhibition of
en in the case of Bf1 (C and C′), Bf2 (D and D′), Fgf8 (E and E′) and Nkx2.4
yos shown in panels G–M were treated by CHX at late gastrula (stage 12), by
la (stage 14). (G and G′) Posterior expansion (arrow) of the Otx2 expression in
1 and G1′) Lateral and posterior expansion of Otx2 expression of two embryos
rrows indicating the posterior limits of expression on the left and right side of
ion (arrows) on the microinjected side. Here and below, all embryos are shown
etrical expansion of expression, which would correspond to the location of
L′) and Nkx2.4 (M and M′). (N and N′) Activation of VP16-Xanf1-BDGR by
icroinjected side (arrow). (O and O′) Control expression of Bf1 as it is seen in
ession of Otx2 in the microinjected embryos treated by DEX alone appeared to
evelopment (compare with panels Q and Q′). (Q and Q′) The Otx2 expression
l area of the inhibited expression (the expression hole) in its central part.
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of 20 embryos in two experiments) (Fig. 3B). At the same time,
no inhibitory influence of EnR-Xanf1-BDGR was revealed in
the cases of Bf1, Bf2, Fgf8 and Nkx2.4 (23, 20, 22 and 21
embryos, respectively, in two experiments), which confirms the
inability of Xanf to interact directly with these genes under the
conditions of this experiment (Figs. 3C–F).
Importantly, in good agreement with our previous data
showing that by itself Xanf1 can act as a strong transcriptional
repressor (Ermakova et al., 1999), direct inhibition of Otx2 and
Pax6 and the absence of inhibition of Bf1, Bf2, Fgf8 and
Nkx2.4 were also observed in similarly arranged experiments
with mRNA encoding a fusion of the full-length Xanf1 and
BDGR (see representative examples for Otx2, Pax6, Bf1 and
Nkx2.4 on Supplementary Figs. 3I–L).
In contrast to the inhibitory effects of EnR-Xanf1-BDGR
and Xanf1-BDGR, an asymmetrical lateral and ventral expan-
sion of the Otx2 and Pax6 expression, in correlation with the
microinjected side of embryo, was observed in embryos
microinjected with the activator-fused construct, VP16-Xanf1-
BDGR, and treated with DEX at the early neurula stage after
CHX application at the end of gastrulation (25 out of 30 and 17
out of 25 embryos, respectively, in two experiments) (Figs. 3G–
G1 for Otx2 and H for Pax6; compare positions of arrows on the
microinjected and non-injected sides of embryos shown on G
and G1). Interestingly, during this we never observed an
expansion of expression along the posterior border of the Otx2
and Pax6 expression domains. This probably indicates that
some strong inhibitors continued to interact with these genes in
cells located just posterior to this border. Nevertheless, the
lateral and ventral expansion of the expression of Pax6 and
Otx2 demonstrated a direct influence of the dominant active
version of Xanf on the expression of these genes. No
asymmetrical expansion of the expression of Otx2 and Pax6
was detected in control embryos incubated with CHX alone (20
and 22 embryos, respectively, in two experiments) (Supple-
mentary Figs. 3E and F). Similarly, no asymmetrical expansion
of expression, which correlated with the microinjected side of
embryo, was detected with four genes that are normally
expressed within the Xanf expression territory: Bf1, Bf2, Fgf8
and Nkx2.4 in embryos microinjected by VP16-Xanf-BDGR
and treated with CHX and DEX (Figs. 3J–M) (24, 22, 23 and 20
embryos, respectively). This result indicates that, in contrast to
its direct regulation of expression of Otx2 and Pax6, Xanf
cannot directly regulate the expression of Bf1, Bf2, Fgf8 or
Nkx2.4.
Interestingly, if the microinjected embryos were not
incubated with CHX but were treated with DEX alone, Bf1,
Bf2, Fgf8 and Nkx2.4 appeared to be strongly inhibited in cells
containing the VP16-Xanf1-BDGR hybrid protein (see Fig. 3N
for Bf1 inhibition; compare with the embryo microinjected by
the same mRNA but not treated by DEX: Fig. 3O). In contrast,
the expression of Otx2 in such embryos was expanded towards
the anterior expression “hole”, the effect very resembling the
expansion of Otx2 expression in Xanf morphants (compare Fig.
3P and Fig. 1C1). Together, these results indicate, that in
embryos expressing the activator-fused variant of Xanf1, inconditions excluding the inhibition of protein synthesis,
inhibition of Bf1 and other forebrain markers could be caused
by the influence of rostral expansion of the Otx2 expression on
the anterior neural plate patterning.
To verify by another approach the ability of Xanf to directly
inhibit the expression of Otx2, we tested whether Xanf could
repress the expression of a DsRed2 fluorescent reporter driven
by the 2.3-kb fragment of the Otx2 5′-flanking region in X.
laevis late blastula animal caps stimulated for neural develop-
ment by noggin. To this end, we microinjected Xenopus
embryos with the reporter plasmid, pOtx2-RFP, mixed with the
mRNA of Xanf-BDGR and noggin. At the late blastula stage,
animal caps of these embryos were cut off and incubated until
the late gastrula stage equivalent (stage 12) when half of the
caps were treated by CHX. After 30 min, DEX was added to
half of the CHX treated and CHX non-treated caps. As a result,
we observed expression of the RFP mRNA or protein
(Supplementary Figs. 3M and O–O′) in caps not treated with
DEX, in which Xanf-BDGR protein was inactive. In contrast,
low expression of the reporter was seen in caps with the
activated Xanf-BDGR (caps treated by DEX) (Supplementary
Figs. 3M and P–P′).
In summary, the results of all these experiments indicate that,
while Xanf can directly downregulate Otx2 and Pax6, which
are normally inhibited within its own expression area, it cannot
regulate Bf1, Bf2, Fgf8 and Nkx2.4, which are co-expressed
with Xanf in the more anterior region of the neural plate.
Downregulation of Xanf leads to reduction of the rostral
forebrain
To investigate the later effects of Xanf downregulation, we
analyzed brain abnormalities in tadpoles developed from Xanf
morphants. Despite the variation in the abnormalities in
individual tadpoles due to different distributions of micro-
injected MO, two main features in the brains of morphants
appeared strikingly different, easily distinguishing these brains
from the controls.
First, the forebrain was severely reduced at its anterior (Figs.
4B, D and F), whereas the ventral and posterior regions of the
rostral forebrain appeared most affected (bracketed on Figs. 4E
and F). In normal Xenopus brains, this region includes such
structures as the anterior preoptic area, lamina terminalis/nervus
terminalis, magnocellular preoptic nucleus, habnular commis-
sure, and a portion of the primordium piriforme (G. Eagleson,
personal communication). Second, the majority of tadpoles had
small fused or even single cyclopic eyes (Fig. 4B). In a
significant portion of tadpoles (15% of 130 in three experi-
ments), this cyclopic phenotype was accompanied by abnormal
differentiation of retinal pigmented epithelium (RPE) in the di-
and telencephalon (Figs. 4D and F arrows).
To analyze these and other less obvious abnormalities in
greater detail, we processed brains of the morphants and
controls for whole-mount in situ hybridization using probes to
different molecular markers. While no changes in expression of
Otx2were revealed in the mesencephalon of morphants, the size
of the diencephalon was reduced, and the diencephalic domain
Fig. 4. Whole heads and extirpated brains of tadpoles (stages 46–47)
developed from embryos microinjected with mis-anti-Xanf (control) and
anti-Xanf MO. Note the tadpole of the latter type shown in this panel has a
middle degree of forebrain reduction. Heads (A and B) and brains are
shown from dorsal (A–D) or lateral side (E and F), anterior to the top.
Arrows indicate ectopic differentiation of pigment epithelium in the brain of
embryos microinjected with anti-Xanf MO. Di—diencephalon, inf—
infundibulum, hth—hypothalamus, mes—mesencephalon, pth—prethalamus,
pt—pretectum, t—tectum, tel—telencephalon, th—thalamus, zli—zona limi-
tance intrathalamica.
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A3). In the control, the Otx2 diencephalic domain of expression
appeared as two thin bilateral branches in the ventricular layer
of the 3rd brain ventricle. Such structures were absent in
morphants, where the medial dorsal stripe was also expanded
more rostrally and laterally.
In the case of Pax6, there was an overall increase of its
expression level in the morphant rostral forebrains (Figs. 5B–
B3). Moreover, this was accompanied by a ventral spreading of
expression. The latter effect was more evident in more severely
malformed brains, which had cyclopic eyes and ectopic
differentiation of RPE in the telencephalon and diencephalon.
Assuming an ability of Pax6 to induce differentiation of RPE
(Chow et al., 1999), one may hypothesize that the observed
ectopic differentiation of RPE cells results from the anterior andventral shift of Pax6 expression in the forebrains of Xanf
morphants.
Dramatic changes were detected in the expression pattern of
Six3. Thus, while the lateral view of the expression pattern
appeared as like several separated spots in controls, in
morphants, they appeared as one continuous domain (compare
Figs. 5C2 and C3) illustrating severe abnormalities in forebrain
patterning. This suggestion was confirmed by the fact that the
zona limitance intrathalamica (zli) demarcated by a triangle-
shaped expression of Nkx2.4 in morphants was reduced in size
(compare Figs. 5D2 and D3). Coincidentally, the expression of
telencephalic markers, Bf1 and Emx1, was significantly
diminished in morphant brains (Figs. 5E–E3 and F–F3).
However, despite a reduction in their expression, the overall
pattern of expression of these two genes was maintained.
In summary, this study confirms that reduction of rostral
forebrain differentiation in Xanf morphants is accompanied by
an anterior and ventral shift in the expression of di- and
mesencephalic markers.
Overexpression of Otx2 within cells of the anterior neural plate
leads to brain abnormalities similar to those elicited by Xanf
MO
As downregulation of Xanf elicited anterior expansion of
expression of a potent brain regulator, Otx2, it seemed
reasonable to suggest that the observed abnormalities of the
anterior neural patterning, as well as further forebrain
malformations, could result from this expansion. To verify
this, we performed experiments in which the anterior expansion
of Otx2 expression was achieved directly by overexpressing
exogenous Otx2 within the expression territory of the
endogenous Xanf. To this end, two strategies were used.
First, we microinjected animal dorsal blastomeres of 32-cell
stage embryos with Otx2 mRNA. At the mid-neurula stage,
embryos with FLD tracer in anterior neural plate cells were
selected and analyzed for the expression of Pax6 and the rostral
markers, Bf1 and Fgf8. Some embryos that were incubated until
the tadpole stage were inspected for forebrain abnormalities. As
a result, strong inhibition of Bf1 and Fgf8 (21 and 19 embryos
in two experiments) was detected at the anterior margin of the
neural plate (Figs. 6A–D′). At the same time, there was an
expansion of the anterior domain of Pax6 expression (17
embryos), resembling the expansion of the Pax6 expression
observed in embryos microinjected with anti-Xanf MO (Figs.
6E–F′). In contrast to latter embryos, however, some decreased
level of the Pax6 expression was regularly seen in the medial
sector of the anterior neural plate of embryos microinjected with
Otx2 mRNA (Fig. 6F). Probably, such a decrease of the Pax6
expression could be explained by inhibitory influence of the
endogenous Xanf, which, in contrast to experiments with anti-
Xanf MO, was not downregulated. Except for the last effect, the
expression abnormalities of the anterior marker genes detected
in embryos with the ectopic expression of Otx2 very much
resembled those observed in embryos microinjected with Xanf
MO. In addition, developing tadpoles had a reduced tele-
ncephalon and cyclopic eyes, thereby also demonstrating a
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Figs. 6G and 4B).
As a second way to precisely target the Otx2 expression to
the rostral part of the neural plate, we used a transgenic
technique in which Otx2 was expressed under the control of a
2.2-kb fragment of the Xanf1 5′ non-coding region. This
promoter fragment was shown previously to be sufficient to
ensure an expression pattern of the transgene similar to that of
endogenous Xanf1 (Eroshkin et al., 2002; Martynova et al.,
2004). This Xanf1-Otx2 cassette was used in the double-
cassette vector, which also contained a cDNA of Red
Fluorescent Protein, RFP (Matz et al., 1999), controlled by
the cardiac actin promoter (see principal scheme of the vector
on Supplementary Fig. 4). This allowed one to readily select
transgenic embryos by detecting red fluorescence in somite
mesoderm (Chae et al., 2002). Alternatively, the embryos could
be distinguished by in situ hybridization using a probe for RFP
mRNA. As a result, we observed a similar inhibition of the
rostral forebrain marker Bf1 (Fig. 6H), and a reduction of the
forebrain (Fig. 6I) as was observed in embryos microinjected
with Otx2 mRNA. Notably, the extent of Bf1 downregulation
varied between embryos, possibly depending on the number of
copies of the transgenic construct within a particular genome
(see examples of transgenic embryos in Supplementary Figs.
4D–G). In contrast, no inhibition of forebrain markers or
reduction of the forebrain was observed in the control transgenic
embryos bearing a single-cassette vector with RFP driven by the
cardiac actin promoter (Supplementary Figs. 4B and C; Figs.
6K and L).
In summary, the data obtained from these experiments
indicate that inhibition of Otx2 expression in the most rostral
region of the neural plate during neurulation is a critical factor
for normal rostral forebrain development.
Discussion
In the present work, we report two novel and important
findings. First, we demonstrate for the first time that the activity
of the Xanf homeodomain transcription factor in the most
rostral sector of the anterior neural plate is essential to inhibit
the expression of two key brain regulators, Otx2 and Pax6, in
this sector. Second, we have presented direct evidence that the
inhibition of Otx2 in this region of the neural plate is necessary
for rostral forebrain development.
Downregulation of Otx2 and Pax6 by Xanf in cells of the
anterior neural plate is critical for rostral forebrain
development
Expression of Otx2 and Pax6 in the anterior neuroectoderm
of the X. laevis embryo has very dynamic characteristics. At the
end of gastrulation, i.e., soon after the initiation of XanfFig. 5. Expression of different markers in brains of tadpoles (stages 46–47) developed
of the telencephalon and the anterior (ventral) diencephalic structures, which include
intrathalamica (zli). At the same time, the more posterior brain regions, including teexpression, Otx2 and Pax6 are still expressed in continuous
domains without any gaps (Ermakova et al., 1999). However,
by the midneurula stage, both genes appear to be inhibited in the
medial sector of the anterior neural plate, just within the
territory corresponding to the expression domain of Xanf. This
area of inhibition appears as a hole within an area of broad
expression of Otx2, or like a medial zone of decreased
expression in a more narrow transverse expression band of
Pax6. While ectopic Xanf was shown to be able to inhibit the
expression of Otx2 and Pax6 (Ermakova et al., 1999), it still be
unknown whether the activity of Xanf is the essential factor that
ensures inhibition of these genes in normal development.
We now present evidence that this is really the case, as the
experimentally induced knockdown of Xanf is essential to elicit
rostral expansion of Otx2 and Pax6 expression towards zones
where they are inhibited during normal development. In
contrast, such genes as Bf1, Bf2, Fgf8 and Nkx2.4, which are
co-expressed with Xanf in the latter territory in normal
development, appeared to be inhibited in embryos with
downregulated Xanf. During further development, these
embryos demonstrated reduced eyes and rostral forebrains.
Importantly, we have consistently observed a similar brain
phenotype accompanied by downregulation of rostral forebrain
markers in embryos with artificially induced expression of Otx2
within the endogenous Xanf expression territory. This result
independently confirms the specificity of the data obtained in
the knockdown experiments with anti-Xanf MO, and it also
directly demonstrates that the anterior inhibition of Otx2 is
necessary for rostral forebrain development.
In the case of Pax6, the importance of its inhibition in the
medial sector of anterior neural plate, i.e., in the territory
corresponding to the Anf expression domain, is confirmed by
the fact that experimentally induced expression of Pax6 within
this territory elicits the formation of a continuous eye field
followed by medial fusion of eye rudiments and even cyclopia
(Chow et al., 1999; Hirsch and Harris, 1997). Interestingly, a
similar phenotype is observed in patients with septo-optical
displasia syndrome caused by mutations in the human
homologue of Xanf, Hesx1 (Dattani et al., 1998). Taking into
account these data along with results obtained in the present
work, one may hypothesize that septo-optical displasia could be
elicited, at least partially, by an abnormal spreading of Pax6
expression to the medial sector of the anterior neural plate, in
which Pax6 is inhibited by Hesx1 during normal development.
At least a temporal downregulation of expression of Otx2
and Pax6 during neurulation at the rostral end of the neural
anlage, within the expression territory of the Anf homeobox, is a
universal feature of anterior neural plate patterning in all
vertebrates, including fish, birds and mammals (Heisenberg et
al., 1996; Lagutin et al., 2003; Masai et al., 1997; Spieler et al.,
2004). A mutually exclusive character of expression was also
reported for the mammalian Anf, Hesx1, and another Otx gene,from embryos microinjected with anti-Xanf MO. Note the significant reduction
infundibulum (inf), hypothalamus (hth), prethalamus (pth) and zona limitance
ctum (t) and thalamus (th), appear normal.
Fig. 6. Anterior expansion of Otx2 expression elicits abnormalities similar to those generated by anti-Xanf MO. (A, C and E) Expression of Bf1, Fgf8 and Pax6 in
control midneurula embryos (stage 14). (B, B′, D, D′ and F, F′) In embryos microinjected with Otx2 mRNA into animal dorsal blastomeres at the 8-cell stage, Bf1 and
Fgf8 are strongly inhibited, while expression of Pax6 is expanded towards the medial sector of the anterior neural plate. (G and J) In contrast to the control (J), the
experimental (G) tadpole (stages 46–47) that developed from the embryo microinjected with Otx2 mRNA has a phenotype resembling the phenotype of tadpoles
which developed from embryos microinjected with anti-Xanf MO (compare with Fig. 4B). (H) Transgenic embryo (stage 14) bearing the double-cassette vector
(pXanf-Otx2-pCardActin-RFP) that targets expression of Otx2 towards the area, in which expression of the endogenous Otx2 is normally inhibited under the influence
of Xanf, demonstrates the reduction of the telencephalic marker, Bf1, expression. (K) Control transgenic embryo (stage 14) expressing RFP under the control of the
cardiac actin promoter demonstrates normal expression of Bf1. Note that RFP expression corresponding to two longitudinal stripes of somite mesoderm and revealed
by in situ hybridization, along with the expression of Bf1 in embryos shown in panels H and K, confirm transgenic status of both embryos. (I and L) Tadpole (stages
46–47) that developed from transgenic embryos bearing pXanf-Otx2-pCardActin-RFP demonstrates a phenotype (I) similar to that of tadpoles that developed from
embryos microinjected with anti-Xanf MO or Otx2 mRNA (compare with Fig. 4B and panel G of this figure). At the same time, control transgenic embryos bearing
pCardActin-RFP construct demonstrate a normal phenotype (L).
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data, together with the results obtained in the present study,
confirm a critical role for inhibition of the posterior forebrain
regulators within the Anf expression territory for rostral
forebrain development in vertebrates.
It has been previously shown that Xanf1 and its orthologues
in chick and mammals could operate as transcriptional
repressors (Dasen et al., 2001; Ermakova et al., 1999; Spieler
et al., 2004). In particular, we demonstrate that when Xanf1 was
expressed ectopically, it could inhibit expression of both Otx2
and Pax6 (Ermakova et al., 1999). By using hormone-inducible
activator- and repressor-fused variants of Xanf1, we have now
obtained evidence that Xanf can directly interact with Otx2 and
Pax6 genes during this inhibition. In contrast, we have shown
that Xanf cannot directly regulate the expression of at least
some genes, namely, Bf1, Bf2, Fgf8 and Nkx2.4, which are
normally co-expressed with Xanf in a more anterior region of
the neural plate. Taken together, these results explain how the
inhibitory activity of Xanf and its orthologues in other species
can discriminate anterior forebrain regulators in favor of
posterior ones.
It should be noted that downregulation of Xanf in our
experiments never resulted in a complete disappearance of the
rostral forebrain. Even in cases of extreme phenotypes, a greatly
reduced telencephalon marked by the expression of Bf1 stilldeveloped. Interestingly, a similar effect was observed in Hesx1
knockout mice, an orthologue of Xanf (Dattani et al., 1998;
Martinez-Barbera et al., 2000). These mice also had varying
degrees of forebrain reduction, but never demonstrated a total
absence of forebrains. Such a partial preservation of the normal
phenotype indicates that Xanf and its homologues in other
vertebrates may control only part of the complex program
responsible for rostral forebrain development.
As previously observed, we consistently saw that Xanf was
restricted in its ability to induce rostral forebrain development.
Thus, ectopic expression of Xanf1 could elicit extra telence-
phalic differentiation only within the rostral forebrain territory
(Ermakova et al., 1999). In contrast, when expressed poster-
iorly, this gene elicited abnormal brain outgrowths, which
followed the identity of the corresponding brain region. Thus,
albeit essential for telencephalic specification, Xanf1 expression
alone is seemingly insufficient to induce the full differentiation
program of the telencephalon. It is more likely that this regulator
can stimulate development of pluripotential nervous tissue,
which requires additional stimuli to differentiate into the rostral
forebrain.
In this context, one may hypothesize that when the Anf class
homeobox first emerged in vertebrate ancestors (see below), the
only role of its repressor activity might have been to create a
piece of unspecified neural tissue at the rostral margin of the
Fig. 7. Emergence of Anf homeobox in evolution correlates with the appearance of a rostral forebrain. (A) Anf-class type of homeodomain, as well as rostral forebrain,
is present only in vertebrates but not in other animal phyla, including closest modern relatives of vertebrates — lower chordates. (B) A possible model for rostral
forebrain evolution as a result of the emergence of Anf genes in vertebrate ancestry. Inhibitory activity of Anf, which emerged in the ancestry of vertebrates, might elicit
downregulation in the rostral region of the neural plate of genes that specified more posterior fates in the chordate ancestry. In turn, this could result in the appearance of
a piece of uncommitted neural tissue. Emerging from executing more posterior functions, this tissue could give rise to the rostral forebrain. Schematic images of neural
plates of vertebrates, low chordates, ancestry of vertebrates and ancestry of chordates are shown from the dorsal side, anterior to the top. Combined expression zone of
Otx2 and Pax6 and their orthologue genes is shown in blue. Patterning of the rostral forebrain primordium in the vertebrate neural plate is inlayed schematically by
green, orange and yellow domains.
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complex forebrain would necessitate many novel mechanisms
that would develop during further evolution. In modern
vertebrates, Anf may still control some of these mechanisms,
whereas others, responsible for the later stages of forebrain
development, may already operate independently of Anf,
eluding its control during evolution. In good agreement with
this model, we have seen partial restoration of forebrain
development in embryos with downregulated Xanf.
Interestingly, downregulation of Xanf activity by MO did not
cause changes in the expression pattern of Wnt8, which is one
of the main Wnts implicated in the regulation of anterior
patterning (Kiecker and Niehrs, 2001). Knockdown of Xanf inour experiments did not disturb expression of Six3, whose
expression is known to be negatively regulated by Wnt
signaling and, in turn, is crucial for the inhibition of Wnt
expression and signaling (Braun et al., 2003; Lagutin et al.,
2003). In contrast, Xanf expression is negatively regulated by
Wnt signaling (Kiecker and Niehrs, 2001). Thus, it was shown
that Xanf expression is activated in the territory corresponding
to the minimum of the anterior–posterior gradient of Wnt
signaling, whereas an increase of Wnt8 level in the anterior
neuroectoderm leads to the inhibition of Xanf1 expression
(Kiecker and Niehrs, 2001).
Together, these data indicate that Xanf probably operates
downstream of the mechanism responsible for Wnt signaling
496 G.V. Ermakova et al. / Developmental Biology 307 (2007) 483–497inhibition, which is implicated as an essential prerequisite for
rostral forebrain specification (Niehrs, 1999). However, further
experiments are necessary to understand the precise chain of
molecular events that activates Xanf expression in the anterior
neuroectodermal cells in response to inhibited Wnt signaling.
Emergence of Anf homeobox in evolution might be a key event
leading to the appearance of the rostral forebrain in
vertebrates
The inhibition of Wnt signaling is thought to be necessary
for rostral structure development not only in vertebrates, but
also in other deuterostomes. Thus, the posterior to anterior
gradient of expression of various Wnts, with the lowest level at
the rostral end of the main embryonic body axis, was also
revealed in echinoderms and lower chordates (Holland, 2002).
At the same time, the rostral forebrain is seemingly a unique
invention present only in vertebrates. This indicates that besides
inhibition of Wnt signaling per se, some other mechanisms that
determine the prospective rostral forebrain area within the most
anterior compartment of the neural plate should be elaborated
during early stages in vertebrate evolution. The results obtained
previously (Masai et al., 1997) and in the present paper suggest
that such a mechanism could be also based on the inhibition of
diencephalic regulators Otx2 and Pax6 by Anf in the most
rostral part of the neural plate. In turn, this predicts that
homologues of these genes may not be inhibited in the
corresponding areas of embryos in lower animals.
Indeed, expression domains of the Otx2 homologues in
ascidia and lancelet midneurulas and of the Pax6 homologue in
lancelet neurula look like a continuous spot or band with no
gaps at the rostral end of the neural plate (Glardon et al., 1998;
Wada et al., 1996; Williams and Holland, 1996). At the same
time, the lancelet and ascidia homologues of two vertebrate
markers of the rostral forebrain, Bf1 and Emx1, are expressed
during neurulation outside the anterior neural plate (Oda and
Saiga, 2001; Toresson et al., 1998). Notably, this picture closely
resembles what is observed in the case of Xanf downregulation
by MO in Xenopus embryos, when rostrally shifted expression
of Otx2 and Pax6 was accompanied by inhibition of Bf1 and
Emx1 in the presumptive rostral forebrain. In turn, continuous
expression domains of Otx2 and Pax6 seen in Xenopus embryos
before neurulation could be considered as a recapitulation of an
ancestral continuous mode of expression now kept by homo-
logues of Otx2 and Pax6 in lower vertebrates. In summary, all
these data indicate that emergence of a mechanism based on
suppression of diencephalic genes within the rostral region of
the neural plate by Anf repressors could be a key event leading
to the development of the rostral forebrain in vertebrates.
Intriguingly, the absence of a rostral zone free of the Otx2
and Pax6 expression in lancelet and ascidia neurulas correlates
with a lack in lower chordate genomes of direct homologues of
the Anf-class of homeobox genes. Indeed, Anf-type proteins
could be easily distinguished from members of other home-
odomain families by specific and conserved amino acid motifs
within the homeodomain and in two regions abutting it
(Kazanskaya et al., 1997). This feature allowed for theidentification of possible orthologues of Anfs in lower animals
by online screening of the available genomic databases or by
RT-PCR with degenerated oligonucleotides. However, no
orthologues of the Anf-class homeobox genes were revealed
in animals other than vertebrates (our unpublished data) (Fig.
7A). This indicates that Anfs could emerge somewhere at the
very beginning of vertebrate evolution (Fig. 7B), possibly as a
result of a duplication of an ancestral paired-type homeobox
gene followed by a quick divergence of one of the duplicated
copies away from the ancestor sequence.
If this is the case, the establishment of the rostral forebrain in
the evolution of vertebrates appears to be correlated in time with
the emergence of Anf genes. Therefore, assuming a key role
played by Anfs in forebrain development, one may hypothesize
that the appearance of these homeobox genes might be the
determining event, which ensured inhibition of expression of
genes that specified the development of more posterior
structures at the anterior end of the neural plate in the ancestors
of vertebrates. In turn, inhibition in this region of more posterior
fates by Anf could result in the appearance of a piece of
uncommited neural tissue. Being uncharged from executing
more posterior functions, this tissue could further evolve into
the rostral forebrain (Fig. 7B).
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